--- title: 'General Interest in Genomenon for B&H: Share your resume and we''ll keep it on file! at Genomenon' canonical: 'https://feeny.ai/job/general-interest-in-genomenon-for-b-h-share-your-resume-and-we-ll-keep-it-on-kdpysq09gdrd' type: 'job' last_seen: '2026-09-07' --- # General Interest in Genomenon for B&H: Share your resume and we'll keep it on file! at Genomenon - **Company:** Genomenon - **Location:** Sarajevo, Bosnia and Herzegovina / Tuzla, Bosnia and Herzegovina - **Work type:** onsite - **Posted:** 2025-11-27 - **Last confirmed live:** 2026-09-07 - **Apply:** https://job-boards.greenhouse.io/genomenoninc/jobs/4620211006 ## Job description Our Company Genomenon is an AI-driven genetic intelligence company on a mission to save and improve lives by making biomedical information actionable. Rare diseases and cancer affect more than 30 million people in the U.S. alone and hundreds of millions globally, yet most patients still face long diagnostic journeys and limited treatment options. Our goal is clear and ambitious: to deliver the information that shapes diagnosis and treatment for every rare disease and cancer patient. We sit at the intersection of AI, genomics, and real world evidence. Genomenon transforms the global scientific literature into a literature derived, real world evidence (RWE) engine for precision medicine—combining large-scale AI with expert human curation to deliver clean, clinically actionable datasets. This approach fills critical gaps left by EHR and claims data, especially in rare disease and oncology, by showing how patients actually present, progress, and respond to therapy. We turn vast, complex biomedical data—spanning genomics, clinical evidence, and scientific literature—into trusted intelligence that helps clinicians make better diagnostic and therapeutic decisions, and supports life sciences organizations in bringing better therapies to market faster. Our work has real, measurable impact. Genomenon’s platforms and services are used by more than 250 clinical laboratories and pharma organizations worldwide to support diagnostic interpretation, variant curation, and evidence-based decision-making across the drug development lifecycle. Each year, our technology helps inform care for tens of thousands of patients facing rare, complex, and time-sensitive conditions—reducing uncertainty and delivering answers when they matter most. What makes Genomenon unique is our ability to support both clinical diagnostics and pharmaceutical innovation on a shared foundation of advanced AI, deep domain expertise, and rigorously curated data. - In the clinic, our solutions directly influence real world patient outcomes. - In pharma, we enable teams to harness literature derived RWE across clinical trial development, regulatory, and commercial workflows—turning fragmented biomedical knowledge into a strategic asset and emerging as the trusted data layer for genomic diagnostics and precision therapeutics. If you’re motivated by impact, energized by complexity, and excited to help shape the future of rare disease diagnosis and treatment, there’s no better place to do that work. Genomenon /ge.gno.mai.non/ Source language: ancient Greek - Verb to come into being to be born out of need - Noun the leader in genomic intelligence Our Community Genomenon team members are thoughtful, ambitious, and mission-driven professionals working across states and countries. Our team brings together scientists, clinicians, engineers, and commercial leaders who collaborate as equals and learn from one another every day. We value curiosity, accountability, and people who thrive in fast-moving, high-impact environments. We are guided by our core values: - Always Learning: Approach challenges with curiosity and a growth mindset - Data-Driven: Ask a lot of questions and look to the evidence for answers - Humbly Confident: Aware of the value that we and others bring to the team - Customer & Patient Driven: Put patients and customers first in everything we do - True Grit:  Embody passion and persistence, and aren’t afraid of hard work Our Company Genomenon is an AI-driven, genomics software company. Our mission is to save and improve lives by making genomic information actionable. We organize the world’s genomic knowledge and put it at the fingertips of clinicians to help diagnose and treat patients suffering from rare diseases and cancer, and to help precision medicine companies create targeted therapies for diseases. There are over 7,000 rare diseases affecting nearly 30 million Americans, 95% of which have no treatment. By harnessing AI and human insight, Genomenon's team is revolutionizing genetic medicine and leading a charge against genetic diseases and cancer for clinicians and pharmaceutical pioneers alike. And the adventure has just begun! Join us in championing the spirit of Genomenon, where every data point is a beacon of hope, every insight a catalyst for change, and every person a vital thread in the fabric of progress. /ge.gno.mai.non/ source language: ancient Greek verb - to come into being - to be born out of need noun - the leader in Genomic Intelligence At Genomenon, we are at the forefront of genomics research and innovation, with a mission to accelerate genetic discoveries and improve patient care. Our Commitment Building a great company starts with building a diverse and inclusive team. We believe that people with different backgrounds, perspectives, and life experiences help us solve harder problems and build better solutions. Genomenon is committed to inclusion across race, gender, age, religion, identity, disability, and background — in how we hire, how we work, and how we lead. If you’re excited about the role but unsure whether you meet every qualification, we encourage you to apply. We’d rather review one more resume than miss the chance to meet someone exceptional. ## About Genomenon ## Company Overview - **One-liner**: Genomenon is an AI-driven genomic intelligence company that structures biomedical literature into real-world evidence to help clinicians diagnose rare diseases and cancer and to help biopharma companies develop targeted therapies. - **Entity Type**: Private (funded with over $50M in capital raised historically) - **Headquarters**: Ann Arbor, Michigan, USA - **Founded**: 2014 - **Founders**: Mark J. Kiel, MD, PhD (CEO & Co-Founder) ## Core Business - **Primary industry**: Genomic Intelligence / Precision Medicine / HealthTech / Biotechnology - **Target customers**: B2B — Clinical diagnostic laboratories (250+ customers), biopharmaceutical companies (75+ drug programs), and research institutions - **Mission**: "To save and improve lives by making genomic information actionable." The company aims to close the "evidence gap" in rare disease and cancer by ensuring clinicians and drug developers have complete, traceable, regulatory-grade evidence. ## Products & Services - **Mastermind**: An AI-powered literature search platform that indexes over 11.2 million full-text articles, 3.7 million supplemental datasets, and 26 million variants. It helps variant interpretation teams find relevant citations faster, reducing VUS (Variants of Uncertain Significance) rates and speeding diagnosis. - **Cancer Knowledgebase (CKB)**: A curated database connecting cancer variants to therapies and clinical trials, used for somatic and germline variant interpretation. - **Custom Real-World Evidence (RWE) Builds**: Tailored evidence packages for biopharma drug programs, supporting label expansion, patient population identification, trial design, and regulatory submissions. ## Market Standing - **Valuation**: Not publicly disclosed (private company) - **Key Metric**: Over 250 clinical diagnostic customers and 75+ biopharma drug programs served - **Notable Investors/Partners**: Not specifically named in public sources, but the company has raised over $50M in capital and had "several successful investor exits" per CEO Mike Klein's background - **Growth Signals**: - LinkedIn followers: 10,458 (growing +1.8% monthly, +25.4% yearly) - Expanding from 5 open roles across QA, Sales, Marketing, and Operations - Operating in the high-growth precision medicine and AI-driven diagnostics space ## Competitive Advantages - **Proprietary AI + Human Curation**: Combines purpose-built AI that reads full-text articles (not just abstracts) with expert scientific curation, creating a regulatory-grade evidence dataset competitors cannot easily replicate. - **Scale of Indexed Data**: 11.2M full-text articles + 3.7M supplemental datasets — far deeper than standard PubMed or abstract-only tools. - **Traceability**: All evidence is traceable to source, which is critical for regulatory submissions and clinical confidence. - **End-to-End Platform**: Serves both clinical diagnostics (Mastermind) and drug development (CKB + RWE), creating a flywheel effect where data from one side improves the other. ## Strategic Focus - **Expanding the evidence base**: Continuously indexing more articles and datasets to close the evidence gap further - **Supporting regulatory approvals**: Helping biopharma partners expand drug labels and optimize trial design with complete genomic evidence - **Scaling customer base**: Growing from 250+ clinical labs and 75+ pharma programs toward broader market adoption - **AI innovation**: Deepening AI/ML capabilities for variant interpretation and evidence extraction ## Why Work Here - **Mission-driven culture**: "Every data point is a beacon of hope, every insight a catalyst for change" — the company is focused on improving patient outcomes in rare disease and cancer - **Remote-first**: Fully remote positions available (US-based, with some roles in Sarajevo/Tuzla, Bosnia & Herzegovina) - **Team composition**: Genetic scientists, PhDs, former clinicians, and experienced professionals — described as "mature and mission-driven" - **Core values**: Customer & Patient Centric, Data-Driven, True Grit, Humbly Confident, Always Learning - **Benefits**: - Equity in Genomenon - Market-based compensation - Flexible Time Off - Paid Family Leave - 401k match - Medical insurance contributions (US employees) - Dental, Vision, and ancillary benefits - Learning and development opportunities - **Diversity commitment**: Explicitly encourages applications from women and people of color, stating "we are committed to inclusion across race, gender, age, religion, identity, disability, and background" ## Sources 1. [genomenon.com](https://www.genomenon.com/) 2. [genomenon.com/careers](https://www.genomenon.com/careers) 3. [genomenon.com/about-us](https://www.genomenon.com/about-us) 4. [job-boards.greenhouse.io/genomenoninc](http://job-boards.greenhouse.io/genomenoninc) 5. [linkedin.com/company/genomenon](https://www.linkedin.com/company/genomenon) ## Other roles at Genomenon - [General Interest in Genomenon: Share your resume and we'll keep it on file!](https://feeny.ai/job/general-interest-in-genomenon-share-your-resume-and-we-ll-keep-it-on-file-n2dej9d8rg4h) — United States